Event Type
Disclosure
Mandatory
Variant
8-K
above. In addition, Omeros can receive (i) up to a total of $510 million in one-time milestone payments upon the first achievement by Novo Nordisk or its affili
above are filed as Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference: ● the Company’s unaudited pro forma condensed consolida
. Financial Statements and Exhibits. (b) Pro forma financial information. The following unaudited pro forma condensed consolidated information reflecting the Tr